Advertisement

Serum Interleukin-18 Levels Are Increased and Closely Associated With Various Soluble Adhesion Molecule Levels in Type 1 Diabetic Patients

  1. Naoto Katakami, MD, PHD1,
  2. Hideaki Kaneto, MD, PHD1,
  3. Munehide Matsuhisa, MD, PHD1,
  4. Kazutomi Yoshiuchi, MD1,
  5. Ken Kato, MD1,
  6. Kaoru Yamamoto, MD1,
  7. Yutaka Umayahara, MD, PHD2,
  8. Keisuke Kosugi, MD, PHD2,
  9. Masatsugu Hori, MD, PHD1 and
  10. Yoshimitsu Yamasaki, MD, PHD1
  1. 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
  2. 2Department of Internal Medicine, Osaka Police Hospital, Osaka, Japan
  1. Address correspondence and reprint requests to Naoto Katakami, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail: katakami{at}medone.med.osaka-u.ac.jp

Recent studies have shown that low-grade inflammation plays an important role in the development of diabetes vascular complications (1). Interleukin-18 (IL-18) is well known to play a key role in various inflammatory and autoimmune diseases (2). IL-18 produces proinflammatory cytokines and upregulates various adhesion molecule expression (3,4). These processes could lead to the development of diabetes vascular complications including atherosclerosis. Indeed, serum IL-18 levels can be a strong predictor of death in patients with cardiovascular diseases (5,6) and is associated with nephropathy and atherosclerosis in type 2 diabetic patients (7).

It was also reported (8) that serum IL-18 levels were increased during the early developing stage of type 1 diabetes, but we cannot exclude the possibility that these results were simply influenced by inflammation at the onset of type 1 diabetes. In this study, we examined serum IL-18 levels in the chronic stage of type 1 diabetes and the possible association between serum IL-18 and various soluble adhesion molecule levels.

RESEARCH DESIGN AND METHODS—

A total of 77 Japanese type 1 diabetic patients (25 men and 52 women, mean ± SD age 23.3 ± 4.4 years, duration of diabetes 13.2 ± …

| Table of Contents
Advertisement